Home Cart 0 Sign in  
X

[ CAS No. 60032-63-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 60032-63-5
Chemical Structure| 60032-63-5
Chemical Structure| 60032-63-5
Structure of 60032-63-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 60032-63-5 ]

Related Doc. of [ 60032-63-5 ]

Alternatived Products of [ 60032-63-5 ]

Product Details of [ 60032-63-5 ]

CAS No. :60032-63-5 MDL No. :MFCD00016983
Formula : C7H5IO2 Boiling Point : -
Linear Structure Formula :- InChI Key :KNQVIRRXVOTGGT-UHFFFAOYSA-N
M.W : 248.02 Pubchem ID :968881
Synonyms :

Calculated chemistry of [ 60032-63-5 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.57
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.62 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 1.68
Log Po/w (WLOGP) : 1.81
Log Po/w (MLOGP) : 1.71
Log Po/w (SILICOS-IT) : 2.47
Consensus Log Po/w : 1.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.81
Solubility : 0.381 mg/ml ; 0.00153 mol/l
Class : Soluble
Log S (Ali) : -2.08
Solubility : 2.07 mg/ml ; 0.00836 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.73
Solubility : 0.465 mg/ml ; 0.00187 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.52

Safety of [ 60032-63-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338-P304+P340-P405-P501 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 60032-63-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 60032-63-5 ]
  • Downstream synthetic route of [ 60032-63-5 ]

[ 60032-63-5 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 60032-63-5 ]
  • [ 77-78-1 ]
  • [ 2314-37-6 ]
Reference: [1] Helvetica Chimica Acta, 1993, vol. 76, # 1, p. 425 - 430
  • 2
  • [ 186581-53-3 ]
  • [ 60032-63-5 ]
  • [ 2314-37-6 ]
Reference: [1] Journal of Agricultural and Food Chemistry, 2005, vol. 53, # 21, p. 8148 - 8155
  • 3
  • [ 123-08-0 ]
  • [ 60032-63-5 ]
YieldReaction ConditionsOperation in experiment
72% With ammonium hydroxide; iodine; potassium iodide In water at 20℃; for 6 h; To a well stirred solution of KI (1.0 mmol) and I2 (1.0 mmol) in NH4OH (aq) 30percent (5.0 ml) was added p-hydroxybenzaldehyde (1.0 mmol) and the resulting mixture was allowed to react for 6 h at room temperature. The solution was then acidified with HCl (aq) 10percent, and extracted with Et2O (2 x 10 ml). The combined organic phases were dried over Na2SO4 and evaporated to dryness. The desired product was obtained after crystallization from H2O. Yield = 72 percent. Analytical data were identical to those already reported for the same compound.3 Anal. Calcd for C7H5IO2: C, 33.90; H, 2.03; O, 12.90. Found: C, 33.93; H, 2.06, O, 12.94.
70% With potassium hydrogensulfate; isoquinolinium dichromate; potassium iodide In water at 50 - 60℃; General procedure: A centimolar (0.01mol) organic substrate (phenols, anilines,or acetanilides), about 0.01 mol of potassium halide (KBr orKI), 0.001 mol hypervalent Cr (VI) reagent (IQCC orIQDC), and solvent (DCE or ACN) were taken in a previouslycleaned round-bottom flask. About 50 mg of KHSO4 isalso added to the reaction flask. The reaction mixture isrefluxed for about 4–5 h at 50–60C. Progress of the reactionwas monitored by TLC technique. After completion, thereaction mixture is treated with 5percent sodium thiosulfate solutionfollowed by the addition of ether. The aqueous layer wasseparated, dried, and evaporated under vacuum, and purifiedwith column chromatography using chloroform:n-hexane(9:1) as eluent to get pure product.General
70% With tetra-(n-butyl)ammonium iodide; isoquinolinium chlorochromate In water at 25 - 30℃; for 4 h; General procedure: Phenol (1 mmol, 10 mL) dissolved in 1M PEG-600, isoquinolinium dichromate (IQDC) or isoquinolinium chlorochromate (IQCC) reagent, and tetrabutylammonium halide (TBAX) (1.1 mmol each) were taken in a reaction flask and refluxed with constant stirring at about 25 to 30 C, till the completion of reaction, as as certainedby thin layer chromatography. Then the contents of reaction were diluted with ethyl acetate (10 mL) and separated from aqueous layer. Organic layer was then washed two to three time swith 5 mL water and separated. Finally, the resultant mass is dried over sodium sulphate. The anhydrous ethyl acetate layerwas separated under reduced pressure to give crude product, which was further purified by column chromatography (silicagel, 100-200 mesh) using EtOAc-hexane (3:7). For the separation and recyclization of PEG, aqueous mother liquor (reaction mixture of PEG-600 and water) was treated with ether because PEG is insoluble in ether. The aqueous layer obtained after the removal of ether, was then distilled directly at 100 C to remove water and recover PEG-600. The recovered PEG-600 could be reused for consecutive runs.
50% With N-iodo-succinimide In acetic acid at 20℃; for 16 h; INTERMEDIATE 394-Hydroxy-3-iodobenzaldehydeTo a stirred solution of 4-hydroxybenzaldehyde (2.0 g, 16.39 mmol) in AcOH (30 mL) was added N-iodosuccinimide (4.5 g, 19.67 mmol). The reaction mixture was stirred at r.t. for 16 h, then filtered. The filtrate was poured onto water (100 mL) and EtOAc (50 mL) was added. The aqueous fraction was separated, then extracted with EtOAc (3 x 50 mL). The combined organic fractions were washed with water (2 x 20 mL), dried (Na2SO4), filtered and concentrated in vacuo to give the title compound (2.0 g, 50percent) as a white solid that was used without further purification. LCMS (ES-) 247.1 (M-H)", RT 1.44 minutes {Method 9).
49% for 12 h; Inert atmosphere 4-Hydroxybenzaldehyde 32a (5.0 g, 40.90 mmol)Was dissolved in 30 mL of glacial acetic acid,N-Iodosuccinimide (9.20 g, 40.90 mmol)Of glacial acetic acid solution, then add lmL concentrated sulfuric acid, stirring reaction for 12 hours.The reaction solution was poured into 50 mL of water, extracted with ethyl acetate (50 mL of X3) and the organic phases were combined, washed with saturated sodium chloride solution (50 mL of X3), dried over anhydrous sodium sulfate, filtered and the filtrate was concentrated under reduced pressure. Silica gel column chromatography The resulting residue was purified with eluent system A to give the title product, 4-hydroxy-3-iodobenzaldehyde 32b (5.0 g, yellow liquid), yield: 49.0percent.

Reference: [1] Organic Preparations and Procedures International, 2002, vol. 34, # 6, p. 647 - 651
[2] Journal of the Brazilian Chemical Society, 2010, vol. 21, # 1, p. 3 - 6
[3] Journal of Organic Chemistry, 2002, vol. 67, # 24, p. 8622 - 8624
[4] Synthesis, 2010, # 9, p. 1467 - 1472
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 2, p. 769 - 772
[6] Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry, 2016, vol. 46, # 6, p. 832 - 837
[7] Asian Journal of Chemistry, 2018, vol. 30, # 8, p. 1892 - 1896
[8] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 12, p. 3147 - 3149
[9] Helvetica Chimica Acta, 1993, vol. 76, # 1, p. 425 - 430
[10] Journal of Organic Chemistry, 1995, vol. 60, # 21, p. 6829 - 6839
[11] Patent: WO2009/1089, 2008, A1, . Location in patent: Page/Page column 36
[12] Patent: CN103030646, 2016, B, . Location in patent: Paragraph 0630; 0632-0635
[13] Synthesis and Reactivity in Inorganic, Metal-Organic and Nano-Metal Chemistry, 2011, vol. 41, # 3, p. 258 - 261
[14] Journal of Organic Chemistry, 2013, vol. 78, # 17, p. 8680 - 8688
[15] Journal of the Chemical Society, 1950, p. 2824,2830
[16] Journal of medicinal chemistry, 1996, vol. 39, # 24, p. 4804 - 4809
[17] Journal of Medicinal Chemistry, 1999, vol. 42, # 18, p. 3572 - 3587
[18] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 2, p. 463 - 466
[19] Carbohydrate Research, 2005, vol. 340, # 1, p. 15 - 24
[20] Patent: WO2010/123975, 2010, A1, . Location in patent: Page/Page column 89-90
[21] Patent: US2011/3785, 2011, A1, . Location in patent: Page/Page column 13
[22] Patent: US2013/281398, 2013, A1, . Location in patent: Paragraph 0458; 0459
[23] Patent: WO2018/64135, 2018, A1, . Location in patent: Paragraph 0221-0224
  • 4
  • [ 2314-37-6 ]
  • [ 60032-63-5 ]
Reference: [1] Synthesis, 2010, # 16, p. 2776 - 2786
[2] Angewandte Chemie - International Edition, 2013, vol. 52, # 40, p. 10635 - 10638[3] Angew. Chem., 2013, vol. 125, # 40, p. 10829 - 10832,4
[4] Journal of Organic Chemistry, 2017, vol. 82, # 2, p. 1205 - 1217
  • 5
  • [ 67-66-3 ]
  • [ 533-58-4 ]
  • [ 60032-63-5 ]
  • [ 23602-64-4 ]
Reference: [1] Journal of the American Chemical Society, 1950, vol. 72, p. 4324
  • 6
  • [ 53279-82-6 ]
  • [ 60032-63-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2013, vol. 52, # 40, p. 10635 - 10638[2] Angew. Chem., 2013, vol. 125, # 40, p. 10829 - 10832,4
  • 7
  • [ 123-11-5 ]
  • [ 60032-63-5 ]
Reference: [1] Journal of Organic Chemistry, 2017, vol. 82, # 2, p. 1205 - 1217
  • 8
  • [ 123-08-0 ]
  • [ 1948-40-9 ]
  • [ 60032-63-5 ]
Reference: [1] Chemische Berichte, 1895, vol. 28, p. 2410
  • 9
  • [ 50-00-0 ]
  • [ 533-58-4 ]
  • [ 60032-63-5 ]
Reference: [1] Patent: DE105798, , ,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 60032-63-5 ]

Aryls

Chemical Structure| 2314-37-6

[ 2314-37-6 ]

3-Iodo-4-methoxybenzaldehyde

Similarity: 0.90

Chemical Structure| 1761-62-2

[ 1761-62-2 ]

2-Hydroxy-5-iodobenzaldehyde

Similarity: 0.90

Chemical Structure| 90151-01-2

[ 90151-01-2 ]

4-Hydroxy-2-iodobenzaldehyde

Similarity: 0.88

Chemical Structure| 58123-77-6

[ 58123-77-6 ]

3-Hydroxy-4-iodobenzoic acid

Similarity: 0.85

Chemical Structure| 16188-57-1

[ 16188-57-1 ]

2-Iodo-4-methylphenol

Similarity: 0.85

Aldehydes

Chemical Structure| 2314-37-6

[ 2314-37-6 ]

3-Iodo-4-methoxybenzaldehyde

Similarity: 0.90

Chemical Structure| 1761-62-2

[ 1761-62-2 ]

2-Hydroxy-5-iodobenzaldehyde

Similarity: 0.90

Chemical Structure| 90151-01-2

[ 90151-01-2 ]

4-Hydroxy-2-iodobenzaldehyde

Similarity: 0.88

Chemical Structure| 2631-77-8

[ 2631-77-8 ]

3,5-Diiodosalicylaldehyde

Similarity: 0.83

Chemical Structure| 696-41-3

[ 696-41-3 ]

3-Iodobenzaldehyde

Similarity: 0.74